ADRX SCHEDULE 13D: SEC filing
OrbiMed entities
Filed with the SEC on · accession 0000947871-26-000917
ADRX filed a SCHEDULE 13D (schedule 13d) with the SEC on Oct 2, 2026. OrbiMed entities filed a joint filing agreement as part of a Schedule 13D regarding their position in ADARx Pharmaceuticals common stock. The stock moved -6.6% by the first close after the filing.
Summary of the filing
OrbiMed entities filed a joint filing agreement as part of a Schedule 13D regarding their position in ADARx Pharmaceuticals common stock. The agreement confirms the filing is made jointly on behalf of the OrbiMed funds.
Key details
How ADRX stock reacted
Close before
$19.54
Oct 1, 2026
First close after
-6.60%
$18.25
5 trading days
-9.54%
$17.68
Since filing
-32.29%
$13.23
✦ Ask GOAX AI about this filing — what it means for ADRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ADRX?
Click hereFrequently asked questions
What did ADRX file with the SEC on Oct 2, 2026?
ADRX filed a SCHEDULE 13D (SEC filing). OrbiMed entities filed a joint filing agreement as part of a Schedule 13D regarding their position in ADARx Pharmaceuticals common stock. The agreement confirms the filing is made jointly on behalf of the OrbiMed funds.
How do I read a SCHEDULE 13D?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D (schedule 13d): A report the company filed with the SEC (the US market regulator).
How did ADRX stock react to this filing?
ADRX closed at $19.54 before the filing and $18.25 on Oct 2, 2026 (-6.60%). Five trading days later: $17.68 (-9.54%).
Other ADRX SEC filings
Get alerts when ADRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days